SureTrader
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Astex CMO Mohammad AzabThis was a trick question!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 549
Posts 86,872
Boards Moderated 28
Alias Born 09/05/02
160x600 placeholder
Advertisement
China's Xiaomi showed signs of slowing growth, as it announced smartphone sales of 34.7 million units in the first half of the year.
More Top Equities Stories Of The Day
CBS, AT&T Reach New Distribution Deal
Hewlett-Packard Officially Files to Split
Xiaomi Gets New CFO
PayPal to Buy Money Transfer Company Xoom
Facebook to Share Ad Revenue With Video Creators
Woodside's Browse LNG Joint Venture to Commence Early Works
H-P's Enterprise Chief Moves On
Alcoa to Close Smelter in Brazil
DewDiligence Member Level  Friday, 03/02/12 01:07:46 PM
Re: jq1234 post# 138137
Post # of 193105 
Quote:
Astex CMO Mohammad Azab

This was a trick question! Technically, Azab didn’t say what I posted in #msg-72767250; however, he did say something very similar that he characterized as a standing joke among statisticians:

http://www.biotech-now.org/business-and-investments/2012/02/oncology-clinical-trials-secrets-of-success
Quote:
Regarding the statistical evaluation, and the PFS vs overall survival discussion earlier, Dr. Azab throws in the quote of the conference: “The joke among statisticians is that statisticians are the people that think Columbus did not discover America, because at the initial trial design his endpoint was to discover India!” Adaptive trials suffer from the same kind of criticism.

I’ll give you partial credit on the quiz :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist